EMULATE THERAPEUTICS, INC. — Form D

EMULATE THERAPEUTICS, INC. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-24. The offering totals $50.0M, of which $250K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
John T ButtersDirectorSeattle, WA
Lisa C ButtersDirectorSeattle, WA
Chris S RiveraDirectorSeattle, WA
John T ButtersExecutive OfficerSeattle, WA
CHRIS RIVERADirectorSEATTLE, WA
CHRIS RIVERAExecutive OfficerSEATTLE, WA
BENNETT M BUTTERSDirectorSEATTLE, WA
JOHN E KINGMADirectorSEATTLE, WA
JOHN E KINGMAExecutive OfficerSEATTLE, WA
DICK E HENRIQUESDirectorSEATTLE, WA
CHARLES E MCNERNEYDirectorSEATTLE, WA
ANDY E DANIELSDirectorSEATTLE, WA
STEVEN E POPEExecutive OfficerSEATTLE, WA
DAVID W GRIEGERDirectorSEATTLE, WA
UNA E RYANDirectorSEATTLE, WA
CLARK W DONNELLDirectorSEATTLE, WA
DANIEL E KISNERDirectorSEATTLE, WA
NANCY E NORDHOFFDirectorSEATTLE, WA
SEAN E KELLDirectorSEATTLE, WA
NANCY W NORDHOFFDirectorSEATTLE, WA
CHARLES W MCNERNEYDirectorSEATTLE, WA
JOHN W KINGMADirectorSEATTLE, WA
Nancy S NordhoffDirectorSeattle, WA
Charles M McNerneyDirectorSeattle, WA
Daniel S KisnerDirectorSeattle, WA

Other filings by this issuer (9)

FiledFormOfferingSold
2019-09-20D$5.0M$450K
2018-11-19D/A$10.0M$4.1M
2017-11-20D$10.0M$1.0M
2017-05-19D$5.0M$210K
2017-02-23D/A$50.0M$9.6M
2015-06-23D$10.0M$725K
2014-07-21D/A$18.0M$11.5M
2014-02-10D$12.0M$9.2M
2010-04-13D$7.5M$300K

More